Details for New Drug Application (NDA): 200151
✉ Email this page to a colleague
The generic ingredient in SELFEMRA is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
Summary for 200151
Tradename: | SELFEMRA |
Applicant: | Teva Pharms Usa |
Ingredient: | fluoxetine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 200151
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Feb 3, 2014 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 15MG BASE | ||||
Approval Date: | Feb 3, 2014 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Feb 3, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription